Page last updated: 2024-08-24

glucose, (beta-d)-isomer and lobeglitazone

glucose, (beta-d)-isomer has been researched along with lobeglitazone in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Jang, K; Jeon, JY; Kim, MG; Moon, SJ1
Hwang, JG; Kim, YK; Park, MK1
Ahn, SH; Cho, Y; Choi, YJ; Hong, S; Kim, SH; Lee, E; Lee, YH; Seo, DH; Seo, S; Suh, YJ1

Trials

2 trial(s) available for glucose, (beta-d)-isomer and lobeglitazone

ArticleYear
Evaluation of the Pharmacokinetic Interaction Between Lobeglitazone and Dapagliflozin at Steady State.
    Clinical therapeutics, 2020, Volume: 42, Issue:2

    Topics: Adult; Benzhydryl Compounds; Cross-Over Studies; Drug Interactions; Fasting; Glucosides; Healthy Volunteers; Humans; Hypoglycemic Agents; Male; Pyrimidines; Therapeutic Equivalency; Thiazolidinediones; Young Adult

2020
No Relevant Pharmacokinetic Drug-Drug Interaction Between the Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin and Lobeglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, in Healthy Subjects.
    Drug design, development and therapy, 2021, Volume: 15

    Topics: Administration, Oral; Adult; Benzhydryl Compounds; Drug Interactions; Drug Tolerance; Glucosides; Healthy Volunteers; Humans; Male; Middle Aged; PPAR gamma; Pyrimidines; Sodium-Glucose Transporter 2 Inhibitors; Thiazolidinediones; Young Adult

2021

Other Studies

1 other study(ies) available for glucose, (beta-d)-isomer and lobeglitazone

ArticleYear
Effect of Dapagliflozin in Combination with Lobeglitazone and Metformin in Korean Patients with Type 2 Diabetes in Real-World Clinical Practice.
    Yonsei medical journal, 2022, Volume: 63, Issue:9

    Topics: Benzhydryl Compounds; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Metformin; Pyrimidines; Republic of Korea; Thiazolidinediones; Treatment Outcome

2022
chemdatabank.com